News | News By Subject | News by Disease News By Date | Search News

Urinary Retention News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
FDA Panel Expresses Concerns Over Allergan (AGN)-Serenity Drug for Nighttime Urination     10/18/2016
Sophiris Bio Inc. (SPHS) Tanks As Phase 3 Data Indicates Drug May Not Be Effective     12/16/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Small But Tenacious: Two Of San Diego's Emerging Biotechs Sophiris Bio Inc. (SPHS) And Lpath, Inc. (LPTN)     6/26/2014
NovaBay Pharmaceuticals, Inc. (NBY)'s Auriclosene Cuts Down Blockages in Catheters in Phase 2 Trial     9/16/2013
Endo Pharmaceuticals (ENDP) to Buy HealthTronics (HTRN) for $223 Million     5/6/2010
Ranbaxy Laboratories (RANBAXY.BO) Unable to Launch New Generic, Flomax; Shares Fall     3/3/2010
Pfizer Inc. (PFE) To Buy Schwarz Pharma Bladder Drug For $210 Million; Schwarz Shares Surge     4/13/2006

News from Around the Web

Press Releases
Innovus Pharma Launches Its Clinically Proven Urivarx Product For Bladder Health Through Its Beyond Human Sales And Marketing Platform In The United States     12/1/2016
Cytori Therapeutics (CYTX) Cell Therapy Leads To Improved Function And Reduced Scar Tissue In A Urinary Injury Model     6/10/2016
Hyperion Therapeutics (HPTX) Announces Data Published In Genetics In Medicine Showing Blood Ammonia And Glutamine As Predictors Of Hyperammonemic Crises In Patients With Urea Cycle Disorders     1/12/2015
Sophiris Bio Inc. (SPHS) Reports Administrative Interim Analysis For The "PLUS-1" Phase 3 Trial Of PRX302 For Benign Prostatic Hyperplasia     12/15/2014
Hyperion Therapeutics Announces Health Canada Accepts RAVICTI® New Drug Submission With Priority Review     6/3/2014
NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.)' Aganocide Compound, NVC-422, Featured in Drugs of the Future     11/14/2011
NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) Initiates Phase 2 Clinical Trial for the Treatment of Urinary Catheter Blockage and Encrustation     3/2/2011
IMPAX Laboratories, Inc. (IPXL) Receives FDA Approval For Generic Versions Of Urecholine(R) Tablets     11/3/2006
Urology Device Company, Percutaneous Systems Inc. Flush With $5 Million Series C     5/11/2006
Stellar Pharmaceuticals Inc. (SLX.V) Announces Presentation Of NMP22'R' BladderChek'R' Test At The 21st Annual Congress Of The European Association Of Urology     4/10/2006

//-->